Viewing Study NCT05109728


Ignite Creation Date: 2025-12-26 @ 10:34 AM
Ignite Modification Date: 2025-12-29 @ 12:21 PM
Study NCT ID: NCT05109728
Status: RECRUITING
Last Update Posted: 2025-12-02
First Post: 2021-10-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent.
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module